Select Language
COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bronchodilators Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Asthma
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Sympathomimetics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anticholinergics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Phosphodiesterase Inhibitor
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Combination Drugs
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injection
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Inhaler
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boehringer Ingelheim International GmbH
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 F. Hoffmann-La Roche Ltd
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 GlaxoSmithKline plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Novartis AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Pfizer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Sanofi
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Vectura Group plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Bronchodilators Market: Major Drivers and Challenges
Figure 2: Global: Bronchodilators Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Bronchodilators Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Bronchodilators Market: Breakup by Indication (in %), 2020
Figure 5: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2020
Figure 6: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2020
Figure 7: Global: Bronchodilators Market: Breakup by Region (in %), 2020
Figure 8: Global: Bronchodilators (Asthma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Bronchodilators (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Bronchodilators (Injection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: North America: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: North America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: United States: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: United States: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Canada: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Canada: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Asia-Pacific: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: China: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: China: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Japan: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Japan: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: India: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: India: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: South Korea: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: South Korea: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Australia: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Australia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Indonesia: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Others: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Europe: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Europe: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Germany: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Germany: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: France: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: France: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: United Kingdom: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Italy: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Italy: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Spain: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Spain: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Russia: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Russia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Others: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Latin America: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Latin America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Brazil: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Brazil: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Mexico: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Mexico: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Others: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Middle East and Africa: Bronchodilators Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2020
Figure 76: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Global: Bronchodilators Industry: SWOT Analysis
Figure 78: Global: Bronchodilators Industry: Value Chain Analysis
Figure 79: Global: Bronchodilators Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Bronchodilators Market: Competitive Structure
Table 7: Global: Bronchodilators Market: Key Players
10% Free customization
Purchase Options
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at
sales@imarcgroup.com